Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

India flag India · Delayed Price · Currency is INR
210.70
-3.65 (-1.70%)
Mar 9, 2026, 3:21 PM IST
99.91%
Market Cap 2.26B
Revenue (ttm) 979.90M
Net Income (ttm) 82.09M
Shares Out 10.52M
EPS (ttm) 7.76
PE Ratio 27.62
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,800
Average Volume 4,420
Open 213.00
Previous Close 214.35
Day's Range 208.75 - 213.95
52-Week Range 81.10 - 335.00
Beta -0.02
RSI 38.07
Earnings Date May 22, 2026

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health su... [Read more]

Sector Healthcare
Founded 1999
Employees 636
Stock Exchange National Stock Exchange of India
Ticker Symbol MADHAVBAUG
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:MADHAVBAUG's revenue was 898.47 million, a decrease of -9.55% compared to the previous year's 993.31 million. Earnings were 71.36 million, an increase of 260.34%.

Financial Statements

News

There is no news available yet.